Dashboard M. tuberculosis
Repurposing candidates for M. tuberculosis
Mycobacterium tuberculosis
Approved medicines with AI-predicted activity ≥40% against M. tuberculosis, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 1,072
- Existing antimicrobials set aside
- 128
- Needing review
- 74
- Repurposing candidates
- 870
Repurposing candidates for M. tuberculosis
AI prediction · nothing measuredAll 870 repurposing candidates for M. tuberculosis.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- AsenapineExisting use: Bipolar disorder, Bipolar I disorder, Psychosis and 1 more61.8% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Donepezil HydrochlorideExisting use: Alzheimer disease, Dementia61.8% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Mobocertinib SuccinateExisting use: Neoplasm, Non-small cell lung carcinoma61.8% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- BaricitinibExisting use: Rheumatoid arthritis61.6% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Caspofungin AcetateExisting use: Aspergillosis, Candidemia, Candidiasis and 1 more61.6% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Ergoloid MesylatesExisting use: Cardiovascular disease61.6% AI-predicted activityagainst M. tuberculosis2 registered studies
- Icatibant AcetateExisting use: Angioedema, Hereditary angioedema61.6% AI-predicted activityagainst M. tuberculosis33 registered studies
- Tenofovir Alafenamide FumarateExisting use: Chronic hepatitis B virus infection, Hepatitis B virus infection, HIV infection and 2 more61.6% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Triptorelin PamoateExisting use: Central precocious puberty, Metastatic prostate cancer, Neoplasm and 3 more61.5% AI-predicted activityagainst M. tuberculosis50+ registered studies
- IloperidoneExisting use: Psychosis, Schizophrenia61.5% AI-predicted activityagainst M. tuberculosis32 registered studies
- Ganirelix AcetateExisting use: Female infertility, Positive regulation of ovulation, Reproductive Techniques, Assisted61.4% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Bazedoxifene AcetateExisting use: Postmenopausal osteoporosis61.4% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Atorvastatin CalciumExisting use: Abnormal circulating lipid concentration, Acute myocardial infarction, Angina pectoris and 10 more61.2% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Dapiprazole HydrochlorideExisting use: Glaucoma, Mydriasis, Open-angle glaucoma61.2% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- DeucravacitinibExisting use: Psoriasis, Psoriasis vulgaris61.2% AI-predicted activityagainst M. tuberculosis50+ registered studies
- FlutamideExisting use: Carcinoma, Metastatic prostate cancer, Neoplasm and 2 more61.1% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Fostamatinib DisodiumExisting use: Autoimmune thrombocytopenic purpura, Hemorrhage, Thrombocytopenia61.1% AI-predicted activityagainst M. tuberculosis27 registered studies
- Ibutilide FumarateExisting use: Cardiac arrhythmia61.1% AI-predicted activityagainst M. tuberculosis10 registered studies
- LusutrombopagExisting use: Hemorrhage, Thrombocytopenia61.0% AI-predicted activityagainst M. tuberculosis8 registered studies
- DacomitinibExisting use: Neoplasm, Non-small cell lung carcinoma61.0% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Etrasimod ArginineExisting use: Ulcerative colitis61.0% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- Naratriptan HydrochlorideExisting use: Migraine disorder61.0% AI-predicted activityagainst M. tuberculosis4 registered studies
- Histrelin AcetateExisting use: Neoplasm, Prostate adenocarcinoma, Prostate cancer60.9% AI-predicted activityagainst M. tuberculosis13 registered studies
- Lazertinib MesylateExisting use: Non-small cell lung carcinoma60.9% AI-predicted activityagainst M. tuberculosisNo documented evidence found